| Literature DB >> 28606485 |
Bing Gu1, Ting Xu2, Haiquan Kang3, Yanling Xu4, Genyan Liu2, Shiyang Pan2, Huimin Qian5, Ping Ma6.
Abstract
OBJECTIVES: The rapid emergence of drug-resistant Shigella sonnei is a serious public health problem. This study aimed to characterise the antimicrobial resistance patterns, molecular subtypes, and integron types and resistance gene cassettes in S. sonnei from Jiangsu Province, China.Entities:
Keywords: Integron; Multidrug-resistant; PFGE; Resistance; Shigella sonnei
Mesh:
Substances:
Year: 2017 PMID: 28606485 PMCID: PMC7103933 DOI: 10.1016/j.jgar.2017.03.009
Source DB: PubMed Journal: J Glob Antimicrob Resist ISSN: 2213-7165 Impact factor: 4.035
Source of Shigella sonnei strains (n = 340), by year and by city, 2002–2011.
| Characteristic | No. of strains | % |
|---|---|---|
| Year | ||
| 2002 | 6 | 1.8 |
| 2003 | 2 | 0.6 |
| 2004 | 6 | 1.8 |
| 2005 | 7 | 2.1 |
| 2006 | 19 | 5.6 |
| 2007 | 48 | 14.1 |
| 2008 | 89 | 26.2 |
| 2009 | 98 | 28.8 |
| 2010 | 33 | 9.7 |
| 2011 | 32 | 9.4 |
| City | ||
| Changzhou | 75 | 22.1 |
| Huai’an | 15 | 4.4 |
| Lianyungang | 21 | 6.2 |
| Nanjing | 36 | 10.6 |
| Nantong | 63 | 18.5 |
| Suqian | 0 | 0.0 |
| Suzhou | 22 | 6.5 |
| Taizhou | 4 | 1.2 |
| Wuxi | 28 | 8.2 |
| Xuzhou | 27 | 7.9 |
| Yancheng | 7 | 2.1 |
| Yangzhou | 17 | 5.0 |
| Zhenjiang | 25 | 7.4 |
Antimicrobial resistance of Shigella sonnei, 2006–2011.
| Antimicrobial agent | Resistant [% ( | ||||||
|---|---|---|---|---|---|---|---|
| 2006 ( | 2007 ( | 2008 ( | 2009 ( | 2010 ( | 2011 ( | Overall ( | |
| Ampicillin | 52.6 (10) | 81.3 (39) | 48.3 (43) | 77.6 (76) | 60.6 (20) | 87.5 (28) | 67.7 (216) |
| AMC | 52.6 (10) | 97.9 (47) | 39.3 (35) | 30.6 (30) | 0.0 (0) | 18.8 (6) | 40.1 (128) |
| Cefalotin | 52.6 (10) | 33.3 (16) | 15.7 (14) | 45.9 (45) | 27.3 (9) | 25.0 (8) | 32.0 (102) |
| Cefotaxime | 5.3 (1) | 14.6 (7) | 12.4 (11) | 30.6 (30) | 21.2 (7) | 3.1 (1) | 17.9 (57) |
| Gentamicin | 26.3 (5) | 8.3 (4) | 39.3 (35) | 34.7 (34) | 33.3 (11) | 78.1 (25) | 35.7 (114) |
| Nalidixic acid | 78.9 (15) | 95.8 (46) | 61.8 (55) | 76.5 (75) | 63.6 (21) | 87.5 (28) | 75.2 (240) |
| Norfloxacin | 26.3 (5) | 25.0 (12) | 4.5 (4) | 46.9 (46) | 0.0 (0) | 0.0 (0) | 21.0 (67) |
| Tetracycline | 73.7 (14) | 93.8 (45) | 58.4 (52) | 73.5 (72) | 72.7 (24) | 87.5 (28) | 73.7 (235) |
| SXT | 68.4 (13) | 72.9 (35) | 64.0 (57) | 65.3 (64) | 81.8 (27) | 71.9 (23) | 68.7 (219) |
AMC, amoxicillin/clavulanic acid; SXT, trimethoprim/sulfamethoxazole.
Antimicrobial resistance of Shigella sonnei from South, Centre and North Jiangsu, 2006–2011.
| Antimicrobial agent | Resistant [% ( | |||
|---|---|---|---|---|
| South ( | Centre ( | North ( | ||
| Ampicillin | 69.9 (123) | 76.9 (60) | 50.8 (33) | 0.003 |
| AMC | 38.1 (67) | 33.3 (26) | 53.8 (35) | 0.032 |
| Cefalotin | 24.4 (43) | 51.3 (40) | 29.2 (19) | <0.001 |
| Cefotaxime | 13.6 (24) | 30.8 (24) | 13.8 (9) | 0.003 |
| Gentamicin | 40.9 (72) | 38.5 (30) | 18.5 (12) | 0.005 |
| Nalidixic acid | 79.0 (139) | 78.2 (61) | 61.5 (40) | 0.016 |
| Norfloxacin | 9.1 (16) | 48.7 (38) | 20.0 (13) | <0.001 |
| Tetracycline | 76.7 (135) | 75.6 (59) | 63.1 (41) | 0.093 |
| STX | 76.1 (134) | 65.4 (51) | 52.3 (34) | 0.001 |
AMC, amoxicillin/clavulanic acid; SXT, trimethoprim/sulfamethoxazole.
Fig. 1Multidrug resistance rates in different cities of Jiangsu Province. CZ, Changzhou; HA, Huai’an; LYG, Lianyungang; NJ, Nanjing; NT, Nantong; SQ, Suqian; SZ, Suzhou; TZ, Taizhou; WX, Wuxi; XZ, Xuzhou; YC, Yancheng; YZ, Yangzhou; ZJ, Zhenjiang.
Rates of integron-positive strains from 2002–2011.
| Year | Class 1 integron | Class 2 integron | Atypical class 1 integron |
|---|---|---|---|
| 2002 | 0.0 (0/6) | 100.0 (6/6) | 100.0 (6/6) |
| 2003 | 50.0 (1/2) | 50.0 (1/2) | 100.0 (2/2) |
| 2004 | 50.0 (3/6) | 100.0 (6/6) | 100.0 (6/6) |
| 2005 | 100.0 (7/7) | 100.0 (7/7) | 100.0 (7/7) |
| 2006 | 57.9 (11/19) | 94.7 (18/19) | 84.2 (16/19) |
| 2007 | 77.1 (37/48) | 93.8 (45/48) | 87.5 (42/48) |
| 2008 | 33.7 (30/89) | 75.3 (67/89) | 23.6 (21/89) |
| 2009 | 66.3 (65/98) | 74.5 (73/98) | 56.1 (55/98) |
| 2010 | 48.5 (16/33) | 72.7 (24/33) | 18.2 (6/33) |
| 2011 | 62.5 (20/32) | 81.3 (26/32) | 21.9 (7/32) |
| Total | 55.9 (190/340) | 80.3 (273/340) | 49.4 (168/340) |
Correlation between antibiogram profile and class 1 integrons in Shigella sonnei, 2006–2011.
| Antimicrobial agent | Class 1 integron-positive ( | Class 1 integron-negative group ( | |||||
|---|---|---|---|---|---|---|---|
| %R ( | %I ( | %S ( | %R ( | %I ( | %S ( | ||
| Ampicillin | 86.6 (155) | 0.6 (1) | 12.8 (23) | 43.6 (61) | 2.9 (4) | 53.6 (75) | <0.001 |
| AMC | 50.3 (90) | 15.1 (27) | 34.6 (62) | 27.1 (38) | 6.4 (9) | 66.4 (93) | <0.001 |
| Cefalotin | 39.7 (71) | 22.9 (41) | 37.4 (67) | 22.1 (31) | 25.7 (36) | 52.1 (73) | 0.003 |
| Cefotaxime | 23.5 (42) | 14.0 (25) | 62.6 (112) | 10.7 (15) | 9.3 (13) | 80.0 (112) | 0.002 |
| Gentamicin | 40.8 (73) | 6.7 (12) | 52.5 (94) | 29.3 (41) | 2.9 (4) | 67.9 (95) | 0.015 |
| Nalidixic acid | 88.8 (159) | 2.2 (4) | 8.9 (16) | 57.9 (81) | 9.3 (13) | 32.9 (46) | <0.001 |
| Norfloxacin | 31.3 (56) | 5.0 (9) | 63.7 (114) | 7.9 (11) | 5.0 (7) | 87.1 (122) | <0.001 |
| Tetracycline | 87.7 (157) | 0.6 (1) | 11.7 (21) | 55.7 (78) | 2.9 (4) | 41.4 (58) | <0.001 |
| SXT | 78.8 (141) | 2.8 (5) | 18.4 (33) | 55.7 (78) | 10.0 (14) | 34.3 (48) | <0.001 |
%R/I/S, percent resistant/intermediate/susceptible; AMC, amoxicillin/clavulanic acid; SXT, trimethoprim/sulfamethoxazole.
Gene cassette arrays in class 1 integrons from Shigella sonnei, 2002–2011.
| Approximate length (kb) | No. of isolates | Gene cassette array |
|---|---|---|
| 0.15 | 22 | 5′CS and 3′CS |
| 1.5 | 5 | |
| 1.6 | 4 | |
| 2.2 | 42 | |
| 0.15 + 1.5 | 1 | 5′CS and 3′CS, |
| 0.15 + 2.2 | 52 | 5′CS and 3′CS, |
| 0.75 + 2.2 | 1 | |
| 1.5 + 2.2 | 13 | |
| 1.6 + 2.2 | 1 | |
| 0.15 + 0.75 + 2.2 | 1 | 5′CS and 3′CS, |
| 0.15 + 1.5 + 2.2 | 4 | 5′CS and 3′CS, |